(1R,2S)-2-Amino-1,2-diphenylethanolCAS# 23190-16-1 |
- (1S,2R)-2-Amino-1,2-diphenylethanol
Catalog No.:BCC8385
CAS No.:23364-44-5
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 23190-16-1 | SDF | Download SDF |
PubChem ID | 719819 | Appearance | Powder |
Formula | C14H15NO | M.Wt | 213.3 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (1R,2S)-2-amino-1,2-diphenylethanol | ||
SMILES | C1=CC=C(C=C1)C(C(C2=CC=CC=C2)O)N | ||
Standard InChIKey | GEJJWYZZKKKSEV-UONOGXRCSA-N | ||
Standard InChI | InChI=1S/C14H15NO/c15-13(11-7-3-1-4-8-11)14(16)12-9-5-2-6-10-12/h1-10,13-14,16H,15H2/t13-,14+/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
(1R,2S)-2-Amino-1,2-diphenylethanol Dilution Calculator
(1R,2S)-2-Amino-1,2-diphenylethanol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.6882 mL | 23.4412 mL | 46.8823 mL | 93.7647 mL | 117.2058 mL |
5 mM | 0.9376 mL | 4.6882 mL | 9.3765 mL | 18.7529 mL | 23.4412 mL |
10 mM | 0.4688 mL | 2.3441 mL | 4.6882 mL | 9.3765 mL | 11.7206 mL |
50 mM | 0.0938 mL | 0.4688 mL | 0.9376 mL | 1.8753 mL | 2.3441 mL |
100 mM | 0.0469 mL | 0.2344 mL | 0.4688 mL | 0.9376 mL | 1.1721 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Columbianetin acetate
Catalog No.:BCN2652
CAS No.:23180-65-6
- Paeoniflorin
Catalog No.:BCN6301
CAS No.:23180-57-6
- Simiarenone
Catalog No.:BCN5082
CAS No.:2318-78-7
- Senkirkine
Catalog No.:BCN2136
CAS No.:2318-18-5
- Songoramine
Catalog No.:BCN6474
CAS No.:23179-78-4
- Nervosine
Catalog No.:BCN2012
CAS No.:23179-26-2
- Pyrolatin
Catalog No.:BCN8439
CAS No.:23176-70-7
- 3,4-Dimethoxycinnamic acid
Catalog No.:BCN5040
CAS No.:2316-26-9
- H-Glu(OMe)-OMe.HCl
Catalog No.:BCC2932
CAS No.:23150-65-4
- Oxymetazoline HCl
Catalog No.:BCC4333
CAS No.:2315-02-8
- Pentoxyverine Citrate
Catalog No.:BCC4697
CAS No.:23142-01-0
- Vincosamide
Catalog No.:BCN5081
CAS No.:23141-27-7
- Matairesinoside
Catalog No.:BCN7583
CAS No.:23202-85-9
- Ifenprodil hemitartrate
Catalog No.:BCC6688
CAS No.:23210-56-2
- Ifenprodil Tartrate
Catalog No.:BCC4589
CAS No.:23210-58-4
- Doxorubicin
Catalog No.:BCC2082
CAS No.:23214-92-8
- Methoxydienone
Catalog No.:BCC9030
CAS No.:2322-77-2
- 23-Hydroxymangiferonic acid
Catalog No.:BCN4668
CAS No.:232266-08-9
- TR-14035
Catalog No.:BCC4266
CAS No.:232271-19-1
- Ritodrine HCl
Catalog No.:BCC4337
CAS No.:23239-51-2
- 5,7-Diacetoxy-8-methoxyflavone
Catalog No.:BCN5083
CAS No.:23246-80-2
- Riddelline
Catalog No.:BCN2133
CAS No.:23246-96-0
- Dimaprit dihydrochloride
Catalog No.:BCC6672
CAS No.:23256-33-9
- Guanabenz Acetate
Catalog No.:BCC4327
CAS No.:23256-50-0
A solid-state fluorescent host system with a 2(1)-helical column consisting of chiral (1R,2S)-2-amino-1,2-diphenylethanol and fluorescent 1-pyrenecarboxylic acid.[Pubmed:18293291]
Chem Asian J. 2008 Mar 7;3(3):625-629.
A solid-state fluorescent host system was created by self-assembly of a 2(1)-helical columnar organic fluorophore composed of (1R,2S)-2-Amino-1,2-diphenylethanol and fluorescent 1-pyrenecarboxylic acid. This host system has a characteristic 2(1)-helical columnar hydrogen- and ionic-bonded network. Channel-like cavities are formed by self-assembly of this column, and various guest molecules can be included by tuning the packing of this column. Moreover, the solid-state fluorescence of this host system can change according to the included guest molecules. This occurs because of the change in the relative arrangement of the pyrene rings as they adjust to the tuning of the packing of the shared 2(1)-helical column, according to the size of the included guest molecules. Therefore, this host system can recognize slight differences in molecular size and shape.
A solid-state fluorescence sensing system consisting of chiral (1R,2S)-2-amino-1,2-diphenylethanol and fluorescent 2-anthracenecarboxylic acid.[Pubmed:17650013]
Org Lett. 2007 Aug 16;9(17):3457-60.
A solid-state fluorescence sensing system was created by using a chiral supramolecular organic fluorophore having a channel-like cavity composed of (1R,2S)-2-Amino-1,2-diphenylethanol as a chiral molecule and 2-anthracenecarboxylic acid as a fluorescence molecule.
Efficient crystallization-induced dynamic resolution of alpha-substituted carboxylic acids.[Pubmed:15176855]
J Org Chem. 2004 Jun 11;69(12):4256-61.
Herein we present a novel route to enantiomerically enriched chiral alpha-substituted carboxylic acids by crystallization-induced dynamic resolution (CIDR) of their diastereomeric salts with chiral amines. Thus, the racemic alpha-bromo acid 3 is converted reliably with (1R,2S)-2-Amino-1,2-diphenylethanol in the presence of a catalytic amount of tetrabutylammonium bromide into its R-enantiomer 4 in 90% yield with 88% ee. Similarly, the racemic alpha-thiobenzoyl acid 5 could be resolved to 90% ee in 74% yield. Further enrichment to enantiomeric homogeneity could be achieved in both cases by crystallization. In a telescoped, two-step process, S-alpha-thiobenzoyl acid 6 (>or=99.6% ee) was prepared from the racemic bromide 3 in 63% yield. State-of-the-art parallel experimentation enabled rapid screening for suitable dynamic resolution conditions. Kinetic studies defined the influence of temperature, tetrabutylammonium bromide concentration, molarity, and solvent polarity on the resolution rate, product yield, and enantiomeric excess.
An amino alcohol ligand for highly enantioselective addition of organozinc reagents to aldehydes: serendipity rules.[Pubmed:12074650]
Org Lett. 2002 Jun 27;4(13):2133-6.
[reaction: see text] Amino alcohol 4 (or its enantiomer) is prepared in two simple steps. Commercial (1R,2S)-2-Amino-1,2-diphenylethanol is dialkylated with bis(2-bromoethyl) ether. Subsequent hydrogenation over 5% Rh on alumina in the presence of morpholine unexpectedly stops at the hexahydro derivative 4. Amino alcohol 4 promotes the enantioselective addition of diethylzinc to aldehydes at room temperature in up to 99% enantiomeric excess.
Asymmetric synthesis of [2,3-(13)C(2),(15)N]-4-benzyloxy-5,6-diphenyl-2,3,5,6-tetrahydro-4H-oxazine-2-one via lipase TL-mediated kinetic resolution of benzoin: general procedure for the synthesis of [2,3-(13)C(2),(15)N]-L-alanine.[Pubmed:11722198]
J Org Chem. 2001 Nov 30;66(24):8010-4.
Lipase TL-mediated kinetic resolution of benzoin proceeded to give the corresponding optically pure (R)-benzoin (R)-1. On the other hand, (S)-benzoin O-acetate (S)-7 could be hydrolyzed without epimerization to give (S)-benzoin (S)-1 under alkaline conditions. Furthermore, both enantiomers of benzoin (1) were converted to [(15)N]-(1R,2S)- and (1S,2R)- 2-amino-1,2-diphenylethanol (3a and 3b), respectively, according to the procedure reported previously. [2,3-(13)C(2),(15)N]-(5S,6R)-4-benzyloxy-5,6-diphenyl-2,3,5,6-tetrahydro-4H-oxazi ne-2-one (10) was synthesized from ethyl [1,2-(13)C(2)]bromoacetate and (1R,2S)-2-Amino-1,2-diphenylethanol (3b) in three steps. Finally, [2,3-(13)C(2),(15)N]-L-alanine (12) was prepared via alkylation of the lactone 10 and hydrogenation of the alkylated product 11.